Tag: Showing

Cardiology

Type II Diabetes Patients under Sildenafil Citrate: Case Series Showing Benefits and a Side Effect.

Newsemia
Related Articles Type II Diabetes Patients under Sildenafil Citrate: Case Series Showing Benefits and a Side Effect. Case Rep Med. 2020;2020:4065452 Authors: Zimmermann LM, Baptista...
AI/ML

Showing robots how to do your chores

Newsemia
Training interactive robots may one day be an easy job for everyone, even those without programming expertise. Roboticists are developing automated robots that can learn...
Cardiology

Pathologic characteristics of 119 archived specimens showing the phenotypic features of hypoplastic left heart syndrome.

Newsemia
Pathologic characteristics of 119 archived specimens showing the phenotypic features of hypoplastic left heart syndrome. Semin Thorac Cardiovasc Surg. 2020 Feb 21;: Authors: Stephens EH,...
Latest News

Aerpio Pharmaceuticals Presents Data from Fifth Patient Cohort Showing Potential of Topical Ocular Formulation of AKB-9778 Product Candidate When Combined with Prostaglandin in Subjects with Primary Open Angle Glaucoma or Ocular Hypertension

Newsemia
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, announced that...
Latest News

Janssen Presents Initial Results for BCMA CAR-T Therapy JNJ-4528 Showing Early, Deep and High Responses in the Treatment of Relapsed or Refractory Multiple Myeloma

Newsemia
BEERSE, Belgium–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson announced today initial results from the Phase 1b/2 CARTITUDE-1 study (NCT03548207) evaluating the efficacy and...
Latest News

Takeda Presents Long-Term Data in ALK+ NSCLC Showing ALUNBRIG® (brigatinib) Continues to Demonstrate Superiority in the First-Line After Two Years of Follow-Up

Newsemia
CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced updated data from the Phase 3 ALTA-1L trial, which evaluated ALUNBRIG versus crizotinib...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World